Acetylsalicylic acid Recruiting Phase N/A Trials for Coronary Artery Disease (CAD)

IndicationsStatusPurposePhase
RecruitingNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT028370033-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation
NCT04401761A Study to Collect Data on the Treatment Pattern of Xarelto + Acetylsalicylic Acid in the Routine Clinical Practice in Patients Who Are Suffering From a Condition That Narrows the Blood Vessels Supplying the Heart and / or a Condition That Most Commonly Narrows the Blood Vessel in the Legs